Clinical significance of T315I ABL kinase domain mutation detection in patients resistant to imatinib mesylate therapy

  • Ivana Horvat, Margareta Radic Antolic, Renata Zadro, Dubravka Sertic, Boris Labar
  • Biochemia Medica, January 2010, Croatian Society for Medical Biochemistry and Laboratory Medicine
  • DOI: 10.11613/bm.2010.009

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.11613/bm.2010.009

The following have contributed to this page: Ivana Horvat